Patrick Amstutz
Founder at MOLECULAR PARTNERS AG
Net worth: 3 M $ as of 2024-04-29
Patrick Amstutz active positions
| Companies | Position | Start | End |
|---|---|---|---|
| MOLECULAR PARTNERS AG | Director/Board Member | 2017-05-11 | - |
| Chief Executive Officer | 2016-11-06 | - | |
| Founder | 2004-11-22 | - | |
| Chief Operating Officer | 2004-11-22 | 2017-05-11 | |
| Corporate Officer/Principal | 2004-11-22 | 2004-11-22 | |
Swiss Biotech Association
 Swiss Biotech Association Miscellaneous Commercial ServicesCommercial Services Swiss Biotech Association operates as an industry association. The private company is based in Zurich, Switzerland. Michael Altorfer has been the CEO of the Swiss company since 2018. | President | 2022-05-02 | - |
| Corporate Officer/Principal | 2016-12-31 | 2022-05-02 | |
Molecular Partners, Inc.
 Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | Director/Board Member | - | - |
| Chief Executive Officer | - | - |
Career history of Patrick Amstutz
Training of Patrick Amstutz
| University of Zurich | Doctorate Degree |
| Swiss Federal Institute of Technology | Graduate Degree |
Statistics
International
| Switzerland | 5 |
| United States | 2 |
Operational
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Corporate Officer/Principal | 2 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| MOLECULAR PARTNERS AG | Health Technology |
| Private companies | 2 |
|---|---|
Swiss Biotech Association
Swiss Biotech Association Miscellaneous Commercial ServicesCommercial Services Swiss Biotech Association operates as an industry association. The private company is based in Zurich, Switzerland. Michael Altorfer has been the CEO of the Swiss company since 2018. | Commercial Services |
Molecular Partners, Inc.
Molecular Partners, Inc. Pharmaceuticals: MajorHealth Technology Part of Molecular Partners AG, Molecular Partners, Inc. operates as a clinical-stage biopharmaceutical company. The company is based in Cambridge, MA. The CEO of the company is Patrick Amstutz. | Health Technology |
- Stock Market
- Insiders
- Patrick Amstutz
- Experience
